Incyte Corporation (INCY)
NASDAQ·Healthcare·Biotechnology
$125.96
-1.30%
Mkt Cap $24.62B
Analyst Ratings
Buy
19
Hold
5
Sell
0
Price Target (56 analysts)
$108.92
Range $90.00 – $140.00
Implied Upside
-13.5%
Consensus $108.92 vs current $125.96
NASDAQ·Healthcare·Biotechnology
$125.96
-1.30%
Mkt Cap $24.62B
Buy
19
Hold
5
Sell
0
Price Target (56 analysts)
$108.92
Range $90.00 – $140.00
-13.5%
Consensus $108.92 vs current $125.96